Ackroo Inc
XTSX:AKR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ackroo Inc
XTSX:AKR
|
CA |
|
Episil-Precision Inc
TWSE:3016
|
TW |
|
C
|
China NT Pharma Group Company Ltd
HKEX:1011
|
CN |
|
H
|
HiteJinro Holdings Co Ltd
KRX:000140
|
KR |
|
Mahamaya Steel Industries Ltd
NSE:MAHASTEEL
|
IN |
|
Medica Sur SAB de CV
BMV:MEDICAB
|
MX |
|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
JP |
|
S
|
Shell PLC
NYSE:SHEL
|
UK |
|
O
|
Omesti Bhd
KLSE:OMESTI
|
MY |
|
D
|
Dida Inc
HKEX:2559
|
CN |
|
Standex International Corp
NYSE:SXI
|
US |
|
Hindustan Copper Ltd
NSE:HINDCOPPER
|
IN |
|
Lundin Mining Corp
TSX:LUN
|
CA |
|
Jyothy Labs Ltd
BSE:532926
|
IN |
|
Constellium SE
NYSE:CSTM
|
FR |
|
Niigata Kotsu Co Ltd
TSE:9017
|
JP |
Balance Sheet
Balance Sheet Decomposition
Ackroo Inc
Ackroo Inc
Balance Sheet
Ackroo Inc
| Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
3
|
3
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
4
|
4
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
3
|
1
|
2
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Intangible Assets |
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
3
|
2
|
3
|
4
|
3
|
1
|
3
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
|
| Total Assets |
2
N/A
|
1
-45%
|
1
-16%
|
1
-33%
|
2
+230%
|
3
+31%
|
1
-75%
|
1
+101%
|
4
+213%
|
5
+15%
|
2
-64%
|
1
-62%
|
2
+199%
|
3
+37%
|
5
+73%
|
4
-23%
|
8
+127%
|
11
+39%
|
9
-20%
|
8
-14%
|
8
+1%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
2
|
4
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
2
|
0
|
0
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
3
|
4
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
4
|
1
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
4
+45%
|
0
-89%
|
1
+67%
|
0
-43%
|
1
+22%
|
1
+75%
|
1
+3%
|
0
-79%
|
0
+86%
|
1
+59%
|
1
+89%
|
2
+46%
|
2
-6%
|
1
-27%
|
1
-29%
|
6
+668%
|
7
+17%
|
6
-20%
|
6
+5%
|
6
-6%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
9
|
11
|
16
|
16
|
19
|
22
|
23
|
24
|
30
|
8
|
8
|
8
|
9
|
12
|
15
|
15
|
15
|
17
|
20
|
20
|
19
|
|
| Retained Earnings |
11
|
19
|
21
|
22
|
24
|
27
|
30
|
32
|
26
|
4
|
8
|
10
|
11
|
13
|
14
|
15
|
15
|
15
|
18
|
20
|
19
|
|
| Additional Paid In Capital |
1
|
5
|
5
|
5
|
6
|
7
|
7
|
8
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
3
-242%
|
0
N/A
|
0
N/A
|
2
N/A
|
2
+33%
|
0
N/A
|
0
N/A
|
4
+1 082%
|
4
+11%
|
1
-75%
|
1
N/A
|
0
N/A
|
1
+341%
|
3
+223%
|
3
-21%
|
2
-37%
|
4
+123%
|
3
-19%
|
2
-50%
|
2
+31%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-45%
|
1
-16%
|
1
-33%
|
2
+230%
|
3
+31%
|
1
-75%
|
1
+101%
|
4
+213%
|
5
+15%
|
2
-64%
|
1
-62%
|
2
+199%
|
3
+37%
|
5
+73%
|
4
-23%
|
8
+127%
|
11
+39%
|
9
-20%
|
8
-14%
|
8
+1%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
6
|
7
|
17
|
27
|
75
|
76
|
77
|
103
|
116
|
121
|
115
|
|